21 May 2013
Keywords: vernalis, frova, launched, migraine, usa, group, oral
Article | 24 June 2002
Vernalis Group's oral migraine treatment Frova (frovatriptansuccinate) has been launched in the USA. The drug, which was approved
in the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 June 2002
1 July 2002
20 May 2013
© 2013 thepharmaletter.com